Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Other Accumulated Expenses (2023 - 2026)

Profound Medical has reported Other Accumulated Expenses over the past 3 years, most recently at $944000.0 for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 47.67% year-over-year to $944000.0; the TTM value through Dec 2025 reached $944000.0, down 47.67%, while the annual FY2025 figure was $944000.0, 47.67% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $944000.0 at Profound Medical, up from $630000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $1.8 million in Q4 2024 and troughed at $509000.0 in Q2 2025.
  • A 3-year average of $974333.3 and a median of $949500.0 in 2025 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: surged 79.68% in 2024 and later crashed 47.67% in 2025.
  • Year by year, Other Accumulated Expenses stood at $1.0 million in 2023, then surged by 79.68% to $1.8 million in 2024, then crashed by 47.67% to $944000.0 in 2025.
  • Business Quant data shows Other Accumulated Expenses for PROF at $944000.0 in Q4 2025, $630000.0 in Q3 2025, and $509000.0 in Q2 2025.